Commonwealth Equity Services, LLC Celularity Inc Transaction History

Commonwealth Equity Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$0.17 - $0.33 $850 - $1,650	5,000 Added 13.96%	40,820 $10,000
Q3 2023 Oct 23, 2023	BUY	$0.22 - $0.56 $440 - $1,120	2,000 Added 5.91%	35,820 $8,000
Q2 2023 Aug 10, 2023	SELL	$0.42 - $0.81 $798 - $1,539	-1,900 Reduced 5.32%	33,820 $18,000
Q1 2023 May 11, 2023	BUY	$0.56 - $1.15 $280 - $575	500 Added 1.42%	35,720 $22,000
Q4 2022 Feb 07, 2023	SELL	$1.08 - $2.35 $14,893 - $32,406	-13,790 Reduced 28.14%	35,220 $45,000
Q3 2022 Nov 14, 2022	SELL	$0.43 - $4.31 $341 - $3,426	-795 Reduced 1.6%	49,010 $113,000
Q2 2022 Jul 19, 2022	BUY	$2.81 - $12.91 $139,952 - $642,982	49,805 New	49,805 $169,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.